William Baer
Internal Medicine · Grand Rapids, MINPI 1184731333
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Amgen at 45.3% of the total. 2025 is the largest year on record at $628, more than ten times the $12 reported in 2020.
Across 104 payments — averaging $10.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$517
- GSK$107
- Novartis$91
- Antares Pharma, Inc.$85
- Novo Nordisk$64
- Dexcom, Inc.$45
- plus $232 from 9 others
Across 3 payments — averaging $9812.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$29K
What the payments were for
- Food & beverage$1,12999%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 72 | $517 |
| GSK | 6 | $107 |
| Novartis | 4 | $91 |
| Antares Pharma, Inc. | 5 | $85 |
| Novo Nordisk | 3 | $64 |
| Dexcom, Inc. | 2 | $45 |
| Pfizer | 2 | $39 |
| Eisai Inc. | 2 | $39 |
| AstraZeneca | 2 | $32 |
| International Rehabilitative Sciences, Inc | 1 | $27 |
| Heartflow, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Bayer | 1 | $16 |
How this compares
$1,141 in reported general payments places this provider in the 75th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 56 | $66,066 |
| MounjaroTirzepatide | 31 | $40,552 |
| TrulicityDulaglutide | 26 | $37,705 |
| JardianceEmpagliflozin | 26 | $23,723 |
| MyrbetriqMirabegron | 22 | $16,617 |
| XareltoRivaroxaban | 17 | $9,223 |
| Repatha SureclickEvolocumab | 14 | $8,292 |
| DuleraMometasone/Formoterol | 18 | $6,973 |
| NexlizetBempedoic Acid/Ezetimibe | 11 | $4,964 |
| Rosuvastatin Calcium | 189 | $3,973 |
| Levothyroxine Sodium | 183 | $3,461 |
| Risedronate Sodium | 18 | $3,205 |
| Atorvastatin Calcium | 147 | $2,671 |
| Duloxetine Hcl | 57 | $2,234 |
| Ezetimibe | 55 | $2,104 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $19 | $78,25757 claims |
| PfizerEliquis | $39 | $66,06656 claims |
| Esperion Therapeutics, Inc.Nexlizet | $18 | $4,96411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Grand Rapids
- Robert SelfeGrand Rapids$238K
- Celia EganGrand Rapids$54K
- Jeremy GentileGrand Rapids$44K
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
- Saroj NeupaneDetroit$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.